Royal Bank Of Canada Lowers Clorox (NYSE:CLX) Price Target to $127.00

Clorox (NYSE:CLX) had its price objective reduced by analysts at Royal Bank Of Canada from $132.00 to $127.00 in a note issued to investors on Thursday,MarketScreener reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 20.09% from the stock’s current price.

Other analysts have also recently issued research reports about the stock. UBS Group reduced their target price on shares of Clorox from $121.00 to $110.00 and set a “neutral” rating on the stock in a report on Tuesday. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. Citigroup raised their price objective on shares of Clorox from $109.00 to $115.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. TD Cowen lifted their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Finally, Morgan Stanley boosted their target price on shares of Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $115.93.

Clorox Price Performance

Shares of NYSE CLX opened at $105.76 on Thursday. The stock’s 50-day moving average is $114.35 and its two-hundred day moving average is $111.07. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. Clorox has a 1-year low of $96.66 and a 1-year high of $143.96. The company has a market cap of $12.79 billion, a price-to-earnings ratio of 17.30, a price-to-earnings-growth ratio of 0.50 and a beta of 0.65.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the business posted $1.55 EPS. The business’s quarterly revenue was down .8% compared to the same quarter last year. Analysts forecast that Clorox will post 7.15 EPS for the current fiscal year.

Institutional Investors Weigh In On Clorox

Hedge funds and other institutional investors have recently bought and sold shares of the business. Haverford Trust Co grew its holdings in Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after acquiring an additional 84 shares in the last quarter. Canandaigua National Bank & Trust Co. grew its holdings in shares of Clorox by 0.8% during the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after purchasing an additional 94 shares during the last quarter. Field & Main Bank boosted its position in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after purchasing an additional 100 shares during the period. Golden State Wealth Management LLC boosted its holdings in shares of Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after acquiring an additional 100 shares during the period. Finally, Fisher Asset Management LLC increased its holdings in shares of Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after acquiring an additional 102 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.